Life sciences + market access background to ER

I'm a PharmD with 2 yoe in market access and am currently in an expert network firm helping hedge funds conduct their due diligence in healthcare. I'm looking to pivot to equity research since I understand the healthcare market & love the deep dives but need some solid leeway into ER. Is MBA a good route to take? Would the expert network experience be taken into consideration for post-MBA opps? Or are the probabilities really low to even consider this option?

Comments (4)

Most Helpful
dickthesellsider, what's your opinion? Comment below:

MBA is an expensive way to do it. You are an expert (I assume) so having expert network experience doesn't matter cuz you just share your expertise with hedge fund clients. 

You need to show ability to connect your drug expertise with stock analysis and pitch yourself to sell-side analysts. That's more cost effective way to go about it, that's what you will do during MBA too - very few banks explicitly recruit MBA research interns so you need to network on your own to develop more shots on goal. 

ivnat9, what's your opinion? Comment below:

Thanks! When I said expert network firm, I meant I am on their research vertical that connects experts with financial advisory firms and guides research indirectly. Would this help in my goal?

anonymous_IV, what's your opinion? Comment below:

Repudiandae ullam autem quo corrupti illo soluta rerum. Hic corporis voluptates quibusdam non nulla fugit. Molestiae facere earum alias.

Autem ducimus quidem natus voluptas. Nisi debitis sed voluptas dolores ad velit quod. Totam nihil ut corrupti. Nihil quisquam consequuntur velit. Provident voluptate laboriosam ad officia dicta aut. Cum culpa accusamus recusandae autem numquam sint aperiam animi. Enim dicta sed non exercitationem asperiores.

Sit aut quis sequi accusamus id. Commodi dolor et aliquid non. Non doloremque sint dicta explicabo temporibus nihil. Nisi pariatur est eaque. Et eveniet minus quaerat dolorum est est itaque. Repellat cumque eum quia aut et sed. Soluta quo enim saepe inventore magni.

Magni id quis dolores ut a officiis. Ut pariatur nihil ratione nostrum. Et expedita facilis voluptatem sed neque mollitia.

Start Discussion

Career Advancement Opportunities

January 2023 Investment Banking

  • Lazard Freres (+ +) 99.5%
  • Jefferies & Company (▽01) 99.1%
  • Lincoln International (▽01) 98.6%
  • Financial Technology Partners (▽01) 98.1%
  • William Blair (▲08) 97.7%

Overall Employee Satisfaction

January 2023 Investment Banking

  • Canaccord Genuity (▲04) 99.5%
  • William Blair (▲04) 99.0%
  • Lincoln International (▲09) 98.6%
  • Jefferies & Company (▲06) 98.1%
  • Financial Technology Partners (▲09) 97.6%

Professional Growth Opportunities

January 2023 Investment Banking

  • Lazard Freres (▲15) 99.5%
  • Financial Technology Partners (▲09) 99.1%
  • Lincoln International (= =) 98.6%
  • Jefferies & Company (▽03) 98.1%
  • William Blair (▲01) 97.7%

Total Avg Compensation

January 2023 Investment Banking

  • Director/MD (6) $592
  • Vice President (23) $401
  • Associates (134) $264
  • 3rd+ Year Analyst (9) $194
  • 2nd Year Analyst (80) $172
  • 1st Year Analyst (257) $171
  • Intern/Summer Associate (41) $167
  • Intern/Summer Analyst (185) $91